Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening
Tadashi Nakano,1 Takeshi Hayashi,2 Toru Nakagawa,2 Toru Honda,2 Satoshi Owada,3 Hitoshi Endo,3 Masayuki Tatemichi3 1Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, 2Hitachi Health Care Center, Ibaraki, 3Department of Preventive Medicine, Tokai University, School of Medi...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f45b0ff89e2e464f83fb6a97374b829c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f45b0ff89e2e464f83fb6a97374b829c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f45b0ff89e2e464f83fb6a97374b829c2021-12-02T00:41:55ZApplicability of automatic spectral domain optical coherence tomography for glaucoma mass screening1177-5483https://doaj.org/article/f45b0ff89e2e464f83fb6a97374b829c2016-12-01T00:00:00Zhttps://www.dovepress.com/applicability-of-automatic-spectral-domain-optical-coherence-tomograph-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Tadashi Nakano,1 Takeshi Hayashi,2 Toru Nakagawa,2 Toru Honda,2 Satoshi Owada,3 Hitoshi Endo,3 Masayuki Tatemichi3 1Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, 2Hitachi Health Care Center, Ibaraki, 3Department of Preventive Medicine, Tokai University, School of Medicine, Kanagawa, Japan Purpose: To perform a preliminary evaluation of the applicability of automatic spectral domain optical coherence tomography (ASD-OCT) for glaucoma mass screening in a population-based setting. Methods: Information using ASD-OCT (thicknesses of the macular retinal nerve fiber layer [mRNFL], disc retinal nerve fiber layer [dRNFL], ganglion cell layer [GCL] + inner plexiform layer [IPL]; GCL+, and ganglion cell complex [GCL + IPL + RNFL; GCL++]) was obtained from 245 eyes of 123 glaucomatous subjects and 1,454 eyes of 727 normal subjects. For all four measurements, each grid was scored as follows: 2= within 95% of the normal database; 1= within 5%; and 0= within 1%. The sums of each grid (mRNFLs, dRNFLs, GCL+s, and GCL++s) were used as indicators. The effectiveness was estimated by the area under the receiver operating characteristic curve (AUC-ROC). The appropriate algorithm was then applied to 10,145 eyes of 5,088 subjects from the general population (mean age: 50.1±10.3 years). Results: AUC-ROC of mRNFLs, dRNFLs, GCL+s, and GCL++s was 0.927 (95% confidence interval [CI] =0.903–0.950), 0.919 (95% CI =0.899–0.940), 0.972 (95% CI =0.958–0.986), and 0.972 (95% CI =0.957–0.986), respectively. The discriminant analysis demonstrated that the canonical correlation coefficients of mRNFLs, dRNFLs, GCL+s, and dGCL++s were 0.07, 0.255, 0.661, and 0.207, respectively. AUC-ROC of the discriminant value was 0.971 (95% CI =0.956–0.986). The sensitivity/specificity using GCL+s (cutoff =160) was 81.6%/99.9%. This algorithm was applied to the general population, and 1,658 eyes (16.3%) were found to be positive for glaucoma. Conclusion: In the case–control setting, ASD-OCT showed a relatively high performance, and the thickness of the GCL + IPL was the best predictor. However, further prospective studies are needed, in which the results of this study are compared to the general population, because the false-positive rate of glaucoma seems to be high. Keywords: automatic spectral domain optical coherence tomography, glaucoma mass screening, population based, applicabilityNakano THayashi TNakagawa THonda TOwada SEndo HTatemichi MDove Medical Pressarticleautomatic spectral domain optical coherence tomographyglaucoma mass screeningpopulation basedapplicabilityOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 97-103 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
automatic spectral domain optical coherence tomography glaucoma mass screening population based applicability Ophthalmology RE1-994 |
| spellingShingle |
automatic spectral domain optical coherence tomography glaucoma mass screening population based applicability Ophthalmology RE1-994 Nakano T Hayashi T Nakagawa T Honda T Owada S Endo H Tatemichi M Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| description |
Tadashi Nakano,1 Takeshi Hayashi,2 Toru Nakagawa,2 Toru Honda,2 Satoshi Owada,3 Hitoshi Endo,3 Masayuki Tatemichi3 1Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, 2Hitachi Health Care Center, Ibaraki, 3Department of Preventive Medicine, Tokai University, School of Medicine, Kanagawa, Japan Purpose: To perform a preliminary evaluation of the applicability of automatic spectral domain optical coherence tomography (ASD-OCT) for glaucoma mass screening in a population-based setting. Methods: Information using ASD-OCT (thicknesses of the macular retinal nerve fiber layer [mRNFL], disc retinal nerve fiber layer [dRNFL], ganglion cell layer [GCL] + inner plexiform layer [IPL]; GCL+, and ganglion cell complex [GCL + IPL + RNFL; GCL++]) was obtained from 245 eyes of 123 glaucomatous subjects and 1,454 eyes of 727 normal subjects. For all four measurements, each grid was scored as follows: 2= within 95% of the normal database; 1= within 5%; and 0= within 1%. The sums of each grid (mRNFLs, dRNFLs, GCL+s, and GCL++s) were used as indicators. The effectiveness was estimated by the area under the receiver operating characteristic curve (AUC-ROC). The appropriate algorithm was then applied to 10,145 eyes of 5,088 subjects from the general population (mean age: 50.1±10.3 years). Results: AUC-ROC of mRNFLs, dRNFLs, GCL+s, and GCL++s was 0.927 (95% confidence interval [CI] =0.903–0.950), 0.919 (95% CI =0.899–0.940), 0.972 (95% CI =0.958–0.986), and 0.972 (95% CI =0.957–0.986), respectively. The discriminant analysis demonstrated that the canonical correlation coefficients of mRNFLs, dRNFLs, GCL+s, and dGCL++s were 0.07, 0.255, 0.661, and 0.207, respectively. AUC-ROC of the discriminant value was 0.971 (95% CI =0.956–0.986). The sensitivity/specificity using GCL+s (cutoff =160) was 81.6%/99.9%. This algorithm was applied to the general population, and 1,658 eyes (16.3%) were found to be positive for glaucoma. Conclusion: In the case–control setting, ASD-OCT showed a relatively high performance, and the thickness of the GCL + IPL was the best predictor. However, further prospective studies are needed, in which the results of this study are compared to the general population, because the false-positive rate of glaucoma seems to be high. Keywords: automatic spectral domain optical coherence tomography, glaucoma mass screening, population based, applicability |
| format |
article |
| author |
Nakano T Hayashi T Nakagawa T Honda T Owada S Endo H Tatemichi M |
| author_facet |
Nakano T Hayashi T Nakagawa T Honda T Owada S Endo H Tatemichi M |
| author_sort |
Nakano T |
| title |
Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| title_short |
Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| title_full |
Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| title_fullStr |
Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| title_full_unstemmed |
Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| title_sort |
applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/f45b0ff89e2e464f83fb6a97374b829c |
| work_keys_str_mv |
AT nakanot applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT hayashit applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT nakagawat applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT hondat applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT owadas applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT endoh applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening AT tatemichim applicabilityofautomaticspectraldomainopticalcoherencetomographyforglaucomamassscreening |
| _version_ |
1718403592058044416 |